NCT07372157 Neuromuscular Balance Exercise Effects in Overweight and Obese Individuals
| NCT ID | NCT07372157 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Marmara University |
| Condition | Overweight and Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-06-15 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-06-15 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled study aims to evaluate the effects of adding neuromuscular balance exercises to exercise programs on functional capacity, balance, and physical fitness in individuals with obesity. Forty participants will be randomly assigned to either a control group receiving aerobic and strength training exercises or an intervention group receiving aerobic and strength training combined with neuromuscular balance exercises. Both exercise programs will be conducted three times per week for eight weeks. Functional capacity, balance, and physical fitness outcomes will be assessed at baseline and after the intervention period. The findings are expected to contribute to the integration of balance-focused exercises into rehabilitation programs for individuals with obesity.
Eligibility Criteria
Inclusion Criteria: * Volunteering to participate in the study * Having a BMI of 25-35 kg/m2 * Not having undergone any surgical operation in the last 6 months Exclusion Criteria: * Any musculoskeletal disorder or systemic disease that would prevent exercise * Balance problems due to any disease that could prevent exercise * Psychiatric or neurological disease affecting cooperation and cognitive functions * Acute pain for any reason * Chest pain * History of myocardial infarction within the last year * Congestive heart failure * Patient's inability to adhere to treatment
Contact & Investigator
Mine Gülden G Polat, PhD
PRINCIPAL INVESTIGATOR
Marmara University Faculty of Health Sciences
Frequently Asked Questions
Who can join the NCT07372157 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 65 Years, studying Overweight and Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07372157 currently recruiting?
Yes, NCT07372157 is actively recruiting participants. Contact the research team at ekinugur@marun.edu.tr for enrollment information.
Where is the NCT07372157 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07372157 clinical trial?
NCT07372157 is sponsored by Marmara University. The principal investigator is Mine Gülden G Polat, PhD at Marmara University Faculty of Health Sciences. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.